Biocon Sdn Bhd is the manufacturer of the human insulin products, and Duopharma Biotech’s wholly-owned subsidiary Duopharma Marketing Sdn Bhd is Biocon’s authorised distributor and reseller.
KUALA LUMPUR: Duopharma Biotech Bhd
has received a one-year supply deal extension for human insulin products and extra contract value of RM19.6mil from the government.
In a filing with Bursa Malaysia, the company said the contract period would be extended from Dec 2,2020 until Dec 1,2021.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
